These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 18425953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
    Michiels JJ, Berneman ZN, Schroyens W, Van Vliet HH.
    Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
    [Abstract] [Full Text] [Related]

  • 4. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.
    Keller TT, Squizzato A, Middeldorp S.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD005158. PubMed ID: 17636787
    [Abstract] [Full Text] [Related]

  • 5. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL, Algra A, van Gijn J.
    Cochrane Database Syst Rev; 2003 Jul 18; (1):CD001820. PubMed ID: 12535415
    [Abstract] [Full Text] [Related]

  • 6. The use of aspirin in polycythaemia vera and primary thrombocythaemia.
    Willoughby S, Pearson TC.
    Blood Rev; 1998 Mar 18; 12(1):12-22. PubMed ID: 9597194
    [Abstract] [Full Text] [Related]

  • 7. Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial.
    Masarova L, Patel KP, Newberry KJ, Cortes J, Borthakur G, Konopleva M, Estrov Z, Kantarjian H, Verstovsek S.
    Lancet Haematol; 2017 Apr 18; 4(4):e165-e175. PubMed ID: 28291640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.
    Squizzato A, Keller T, Romualdi E, Middeldorp S.
    Cochrane Database Syst Rev; 2011 Jan 19; (1):CD005158. PubMed ID: 21249668
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia.
    Elliott MA, Tefferi A.
    Br J Haematol; 2005 Feb 19; 128(3):275-90. PubMed ID: 15667529
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL, Algra A, van Gijn J.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD001820. PubMed ID: 17636684
    [Abstract] [Full Text] [Related]

  • 16. [Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of register for the 1st quarter of 2010].
    Penka M, Schwarz J, Ovesná P, Hlusí A, Korístek Z, Doubek M, Dulícek P, Pospísilová D, Kissová J, Buliková A, Pavlík T, CZEMP.
    Vnitr Lek; 2010 Jun 18; 56(6):503-12. PubMed ID: 20681462
    [Abstract] [Full Text] [Related]

  • 17. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL, Algra A, van Gijn J.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD001820. PubMed ID: 16625549
    [Abstract] [Full Text] [Related]

  • 18. Low-dose aspirin in polycythemia vera.
    Dutrillaux F, Maynadié M, Carli PM.
    N Engl J Med; 2004 Apr 15; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088322
    [No Abstract] [Full Text] [Related]

  • 19. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA, Kremer LC, van de Wetering MD, van Ommen CH.
    Cochrane Database Syst Rev; 2013 Sep 11; (9):CD009160. PubMed ID: 24026801
    [Abstract] [Full Text] [Related]

  • 20. Triflusal for preventing serious vascular events in people at high risk.
    Costa J, Ferro JM, Matias-Guiu J, Alvarez-Sabin J, Torres F.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD004296. PubMed ID: 16034926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.